Are Psychedelics The Solution To The Opioid C...

For far too long, many women have been told their symptoms were normal, exaggerated, or simply something they had to live with—treated as isolated problems instead of part of a much larger hormonal transition happening inside the body. On this episode of The Dr. Hyman Show, I’m j ...  Show more

Hormone replacement therapy is one of the most talked about—and misunderstood—topics in women’s health. For years, women were told HRT was dangerous. Now, the conversation is shifting, but many are still left confused about what’s actually safe, when to start, and whether hormone ...  Show more

“Ibogaine made them ready for change,” says researcher Deborah Mash, PhD. Mash has been studying the effects of ibogaine since 1992. A psychedelic compound derived from the bark of a shrub native to western central Africa, ibogaine is being used as a potent addiction disruptor (s ...  Show more

When we are in pain, we often turn to over-the-counter medications like acetaminophen. Sometimes, however, we’re prescribed opioid painkillers, and there’s a perception that this will be a more effective treatment, because opiods are the “strongest” treatment. But a lot of what w ...  Show more

Drs Michael S. Saag and Ellen F. Eaton discuss HIV and opioid use disorder, including opioid agonists for chronic pain management, tools for reducing mortality, and management in the outpatient setting. Relevant disclosures can be found with the episode show notes on Medscape (ht ...  Show more

Mark Parrino has been involved with the delivery of health care and treatment for opioid use disorder (OUD) since 1974. As the president of the American Association for the Treatment of Opioid Dependence, Inc. (AATOD), he works with treatment providers across the country to devel ...  Show more